Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of CD318 in Acute Myeloid Leukemia Patients at Assiut University Hospital

NCT04708444 is registered in ClinicalTrials.gov with Shimaa Arafa Ibrahim as lead sponsor.

NCT NCT04708444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04708444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of CD318 in Acute Myeloid Leukemia Patients at Assiut University Hospital
Lead sponsor
Shimaa Arafa Ibrahim
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2021
Completion date
March 31, 2023
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia